upadacitinib
abbvie
['rinvoq', 'upadacitinib']
a higher daily dose of #upadacitinib (#rinvoq) was associated with less severe disease &amp; longer clinical remission for patients with #ulcerativecolitis, reported brian feagan, md, of at #acg2022. #gitwitter
Healthcare is complicated. We explain it. #MedPageToday

Retweets, likes, and comments are not endorsements.